U.S. federal trademark · Serial No. 90273167
Research and development related to platelets, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, including, extracellular vesicles or exosomes; Research and development in the field of allogeneic cell therapy, platelet variants, drug delivery and pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; Biotechnology research; Research in the field of allogeneic cell therapy, platelet variants and pharmaceutical compositions comprising platelet variants; Pharmaceutical research and development; Medical research; Scientific research; Medical and scientific research in the field of allogeneic cell therapy, platelet variants, and pharmaceutical compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; Research and development related to viral vectors and delivery of viral vectors
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.